每经AI快讯，9月29日，京东健康在港交所公告，金恩林已辞任首席执行官，曹冬获委任为公司首席执 行官。 ...

格隆汇9月29日丨京东健康(06618.HK)发布公告，(i)金恩林先生已辞任执行董事、首席执行官、薪酬委 员会成员及授权代表，以投入更多时间于其家庭，自2025年9月29日起生效，及(ii)QingqingYi先生已辞 任非执行董事，自2025年9月30日起生效，原因为其需要更多时间及集中精力处理其他繁重业务。 此外，曹冬先生已获委任为公司执行董事、首席执行官以及授权代表，自2025年9月29日起生效。金先 生辞任后，陈兴垚先生已获委任为薪酬委员会成员，自2025年9月29日起生效。 ...

京东健康股份有限公司（「本公司」）的董事會（「董事會」）成員如下。 執行董事 JD Health International Inc. 京東健康股份有限公司 （於開曼群島註冊成立的有限公司） （股份代號：6618（港幣櫃台）及86618（人民幣櫃台）） 董事名單及其角色和職能 劉強東 （主席） Qingqing Yi 獨立非執行董事 陳興垚 李玲 張吉豫 吳鷹 廖家傑 董事會設有三個委員會。下表詳細列出該等委員會成員。 | 董事 | 審計委員會 | 薪酬委員會 | 提名委員會 | | --- | --- | --- | --- | | 曹冬 | | | | | 劉強東 （主席） | | | 主席 | | Qingqing Yi | | | | | 陳興垚 | 主席 | 成員 | | | 李玲 | 成員 | 主席 | | | 張吉豫 | 成員 | | 成員 | | 吳鷹 | | 成員 | 成員 | | 廖家傑 | | | | 2025年9月29日 曹冬 （首席執行官） 非執行董事 ...

更換董事及授權代表 及 薪酬委員會組成變更 京东健康股份有限公司（「本公司」，連同其子公司「本集團」）董事（「董事」）會（「董事會」） 謹此宣佈以下董事會變更及本公司薪酬委員會（「薪酬委員會」）組成變更。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何 責任。 JD Health International Inc. 京東健康股份有限公司 （於開曼群島註冊成立的有限公司） （股份代號：6618（港幣櫃台）和86618（人民幣櫃台）） 董事辭任 董事會宣佈(i)金恩林先生（「金先生」）已辭任執行董事、首席執行官、薪酬委員會成員及 香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」）第3.05條項下的授權代 表（「授權代表」），以投入更多時間於其家庭，自2025年9月29日起生效，及(ii) Qingqing Yi先生（「Yi先生」）已辭任非執行董事，自2025年9月30日起生效，原因為其需要更多時間 及集中精力處理其他繁重業務。 金先生及Yi先生均已 ...

今年8月14日晚间，京东健康发布2025年中期业绩公告显示，上半年实现总收入为353亿元，同比增长 24.5%；非国际财务报告准则指标下（Non-IFRS）净利润达35.7亿元，同比增长35%。截至2025年6月30 日，京东健康过去12个月的年度活跃用户数量突破2亿；京东互联网医院日均问诊单量超过50万。 在用药指导方面，京东药师可以讲解药品的用法用量、使用禁忌以及出现不良反应时的应对措施；针对 慢病患者，京东药师会为他们建立健康档案，制定个性化用药计划，并进行生活方式干预和定期随访， 必要时还会协调其他优质医疗资源，提升慢病控制效果；京东药师还通过直播、短视频、图文海报等形 式，普及药学知识，提升用户安全用药意识，从源头降低用药风险。 "药师绝不是药品销售员，而是健康的守护者"，京东健康相关负责人表示，《京东药师宣言》不仅是承 诺，更是京东药师的行为准绳。未来，京东药师将持续以专业能力为基础，以用户需求为根本，让用户 的每一次购药都安心，每一次用药都科学合理。 9月25日是第17个"世界药师节"，京东健康最近联合新华网（603888）发布《京东药师宣言》，向行业 顽疾—药品推销"宣战"。京东健康表示，旗下 ...

Core Viewpoint - The article emphasizes the importance of autumn health management according to traditional Chinese medicine, highlighting the need for nourishing the body and preventing dryness during the transition to winter [1][2]. Group 1: Autumn Health Recommendations - Traditional Chinese medicine suggests that autumn is a time to nourish yin and prevent dryness, recommending foods like pears, lilies, and honey to enhance health [1]. - It is advised to avoid excessive spicy foods to prevent worsening internal dryness, while maintaining emotional stability and engaging in gentle exercises like Tai Chi and jogging [1]. Group 2: Digital Health Services - The company has launched a series of health services titled "Scientific Autumn Nourishment, Moisturizing the Lungs to Prevent Dryness," integrating traditional wisdom with modern digital health technologies [1]. - Over 28,000 traditional Chinese medicine practitioners are now available nationwide, with more than 8,000 being senior doctors, providing personalized health solutions based on individual conditions [2]. Group 3: User Experience and Feedback - A user from Beijing reported positive outcomes after receiving a personalized health plan that included traditional Chinese medicine and home herbal tea, leading to improved health after follow-up consultations [2]. - The company is set to enhance its services by addressing common user concerns regarding the bitterness of traditional medicine, offering gifts to make the experience more pleasant [2]. Group 4: Future Developments - The company plans to continue digitalizing and personalizing traditional Chinese medicine services, ensuring convenient and professional health management for users [3].

Core Insights - JD Health has publicly unveiled its latest achievements in building a smart interconnected ecosystem for medical devices, establishing an alliance represented by CGM dynamic blood glucose monitors and AI models [1] - The CGM market has seen significant growth, with JD's CGM category transaction value increasing by over 90% year-on-year since 2025 [2] - The healthcare device industry in China is experiencing rapid growth driven by both policy and market demands, shifting consumer health management from passive treatment to proactive prevention [1][2] Group 1 - JD Health has launched a comprehensive smart blood glucose management system that integrates monitoring, analysis, intervention, and tracking through its AI health assistant "KangKang Blood Sugar" [1][2] - The CGM devices are compact and allow for continuous monitoring over several days, significantly reducing the discomfort associated with traditional blood sampling methods [2] - JD Health plans to expand its health management ecosystem to include other chronic disease areas such as blood pressure, electrocardiograms, and respiratory health [1][3] Group 2 - The company collaborates with brands like Yuyue, Sanofi, and Weitai to offer customized CGM products that provide real-time blood sugar monitoring and alerts through the JD Health app [2] - JD Health leverages its nationwide network of top-tier hospital doctors and various professional services to provide tailored health advice based on comprehensive user data [3] - Future plans include deepening the integration of "medical devices + AI" in health management scenarios, enhancing accessibility to quality healthcare services [3]

Core Insights - The "AI Health Forum" at the 2025 JD Global Technology Explorer Conference showcased the upgraded "Jingyi Qianxun 2.0" medical model and introduced the new "AI Hospital 1.0," which creates an AI-driven closed loop for "medical examination, diagnosis, and medication" [1][2] - JD Health established the "JD Health Intelligent Interconnection Ecological Alliance" with leading medical device brands to build a comprehensive smart health management system integrating hardware, software, services, and ecology [1] - The upgraded "Jingyi Qianxun 2.0" model is the first in the industry to break through credible reasoning and multimodal capabilities, simulating clinical diagnostic thinking and aligning with external evidence to enhance diagnostic accuracy [1][2] Group 1 - The new doctor agent based on "Jingyi Qianxun 2.0" allows for free-form consultations, supporting flexible responses based on professional knowledge and user needs [2] - The AI Hospital 1.0 achieves a service loop from triage to consultation, examination, and medication, optimizing healthcare service efficiency and user experience [2][3] Group 2 - "AI Hospital 1.0" includes over ten types of professional service intelligences and more than 1,000 expert doctor intelligences from over 400 top-tier hospitals, providing 24/7 online services [3] - Since 2025, the AI services have cumulatively served over 150 million users with a satisfaction rate of 97% [3]

Group 1: Event Overview - The 2025 Weibo Health Medical Gala was held in Shanghai, focusing on "Health Without Boundaries: Reshaping Medical Information" [1] - Over 300 guests discussed enhancing the supply of quality health science content and purifying the health science information dissemination environment [1] Group 2: Internet Healthcare Industry Development - The internet healthcare sector is entering a new phase of scale and standardization, with 418 million users projected by the end of 2024, accounting for 37.7% of internet users [3] - The market size of internet healthcare in China is expected to exceed 479.9 billion yuan by 2025, driven by increased health awareness, strong government support, and widespread mobile internet infrastructure [3] - As of September 2025, there are 3,756 internet hospitals in China, with 130 million online consultations completed last year [3] Group 3: JD Health's Achievements - JD Internet Hospital's average daily consultation volume exceeded 500,000 in the first half of 2025, enhancing its service capabilities to meet diverse health needs [4] - The medical team at JD Internet Hospital has an average experience of over 10 years, providing 24/7 professional consultation services [4] - JD Health offers over 60 professional nursing services and rapid testing products, with delivery services available in major cities [4] Group 4: AI Integration in Healthcare - JD Health is exploring artificial intelligence, implementing smart triage, prescription review, and medical record management [5] - The "AI Doctor" product has served over one million users, achieving a satisfaction rate of over 97% [5] - A strict quality control management system has been established, with a consensus on internet hospital medical quality management published in a medical journal [5] Group 5: Future Directions - JD Health aims to enhance medical accessibility, reduce healthcare costs, and improve patient experiences while empowering doctors [6] - The company is committed to transitioning internet healthcare from "precision" to "warmth" [6]

Core Insights - JD Health has launched the exclusive online debut of Bo You Ping (Dulaglutide Injection), a biosimilar for Trulicity, aimed at controlling blood sugar in adults with type 2 diabetes [1][2] - The product is the first and only approved biosimilar of Dulaglutide globally, addressing the growing diabetes prevalence in China, which exceeds 223 million patients [1][2] Company Developments - JD Health partnered with Shanghai Pharmaceuticals to promote Bo You Ping across all channels in mainland China, enhancing its market presence [2] - The collaboration aims to leverage JD Health's established online launch solutions and robust supply chain capabilities to facilitate patient access to innovative treatments [2] Industry Context - Type 2 diabetes is the most common form of diabetes, with traditional treatments facing challenges such as high medication frequency and risks of hypoglycemia [1] - GLP-1 receptor agonists, like Dulaglutide, are recommended for their significant blood sugar-lowering effects, weight loss benefits, and cardiovascular and renal protection [2]